Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma
    Meeting Abstract

    Tao, A. J.; Ecker, B. L.; Janssen, Q.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J. A.; Brennan, M. F.; Kingham, T. P.; Soares, K. C.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Short- and long- term outcomes of minimally invasive vs open gastrectomy after neoadjuvant chemotherapy for gastric cancer
    Meeting Abstract

    Shimada, S.; Abate, M.; Drebin, H. M.; Fei, T.; Janjigian, Y.; Ku, G.; Tang, L.; Coit, D.; Strong, V. E.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Hepatic artery infusion chemotherapy compared to Y90 for treatment of unresectable colorectal liver metastases: A multi-institutional comparative study
    Meeting Abstract

    Saadat, L. V.; Chou, J.; Gonen, M.; Lee, R. M.; Maithel, S. K.; Li, A. Y.; Poultsides, G.; Aiken, T. J.; Schwartz, P. B.; Abbott, D. E.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Organ preservation, compliance and toxicity in rectal cancer patients treated with total neoadjuvant therapy: A post hoc analysis of the of the OPRA phase II trial
    Meeting Abstract

    Verheij, F. S.; Omer, D. M.; Lin, S. T.; Yuval, J. B.; Thompson, H. M.; Kim, J.; Valdivieso, S. C.; Qin, L. X.; Wu, A. J.; Saltz, L. B.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage
    Meeting Abstract

    Sharib, J.; Liu, A.; McIntyre, S.; Rhodin, K. E.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; Abou-Alfa, G. K.; Soares, K. C.; Wei, A. C.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Genetic heterogeneity of intrahepatic cholangiocarcinoma: Implications for outcome
    Meeting Abstract

    Song, Y.; Boerner, T.; Drill, E.; Shin, P.; Cercek, A.; Kemeny, N. E.; Abou-Alfa, G. K.; Iacobuzio-Donahue, C.; Schultz, N.; Walch, H.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Results from an expanded phase 1 trial of botensilimab (BOT), a multifunctional anti-CTLA-4, plus balstilimab (BAL; anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)
    Meeting Abstract

    Bullock, A.; Fakih, M.; Gordon, M.; Tsimberidou, A.; El-Khoueiry, A.; Wilky, B.; Pimentel, A.; Margolin, K.; Mahadevan, D.; Balmanoukian, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: Sensitivity analysis of survival from the NAPOLI 3 trial
    Meeting Abstract

    Wainberg, Z.; Melisi, D.; Macarulla, T.; Cid, R. P.; Chandana, S.; de la Fouchardiere, C.; Dean, A.; Kiss, I.; Lee, W.; Goetze, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes and a prognostic classifier in 130 patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade
    Meeting Abstract

    Randon, G.; Aoki, Y.; Cohen, R.; Nasca, V.; Klempner, S.; Maron, S.; Cerantola, R.; Fornaro, L.; Ambrosini, M.; Manca, P.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Sangro, B.; Chan, S.; Kelley, R.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; De Toni, E.; Furuse, J.; Kang, Y.; Galle, P.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save